North America Cyclodextrin Market Size, Share & Trends Analysis Report By Type (Beta-Cyclodextrin, Alpha-Cyclodextrin, and Gamma-Cyclodextrin), By End-use, By Country and Growth Forecast, 2024 - 2031

North America Cyclodextrin Market Size, Share & Trends Analysis Report By Type (Beta-Cyclodextrin, Alpha-Cyclodextrin, and Gamma-Cyclodextrin), By End-use, By Country and Growth Forecast, 2024 - 2031


The North America Cyclodextrin Market would witness market growth of 5.1% CAGR during the forecast period (2024-2031). In the year 2020, the North America market's volume surged to 231.83 Tonnes, showcasing a growth of 17.3% (2020-2023).

Beta-cyclodextrin, a key component of the market, serves various roles across different industries. In pharmaceuticals, this functions as an excipient, forming inclusion complexes with hydrophobic drugs to enhance their solubility and stability. This enables the formulation of oral medications with improved bioavailability and reduced side effects. Therefore, the demand of this product in the US was 245.37 Tonnes in 2023.

The US market dominated the North America Cyclodextrin Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $162,694.3 Thousands by 2031. The Canada market is experiencing a CAGR of 5.4% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 6.1% during (2024 - 2031).

The market refers to the industry producing, distributing, and utilizing cyclodextrins and its derivatives. These are cyclic oligosaccharides composed of glucose units linked by α-(1,4) glycosidic bonds. They are characterized by a toroidal (doughnut-shaped) structure with a hydrophobic cavity and hydrophilic exterior, which enables them to form inclusion complexes with guest molecules.

Due to their unique molecular structure and encapsulation capabilities, cyclodextrins find various applications across various industries. For example, these are extensively used in the pharmaceutical industry as excipients to enhance poorly water-soluble drugs’ solubility, stability, and bioavailability. They form inclusion complexes with hydrophobic drug molecules, improving their aqueous solubility and facilitating controlled-release formulations.

As Canada’s food and beverage industry expands, there may be a higher demand for food additives, including these chemicals. These are used in the food industry as encapsulating agents, stabilizers, and flavour enhancers. With the introduction of new food products and the reformulation of existing ones to meet consumer demands, these could be needed to improve the taste, texture, and shelf-life of food and beverage products. Thus, the increasing food and beverage industry in the region is driving the market’s growth.

Based on Type, the market is segmented into Beta-Cyclodextrin, Alpha-Cyclodextrin, and Gamma-Cyclodextrin. Based on End-use, the market is segmented into Pharmaceutical, Food, Cosmetics & Personal Care, Chemical, Textile and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled
  • Midas Pharma Gmbh
  • Wacker Chemie AG
  • Roquette Freres SA
  • Cambrex Corporation
  • Wellona Pharma
  • Cayman Chemical Company, Inc.
  • Cyclolab Kft.
  • Ligand Pharmaceuticals Incorporated
  • Tocopharm Co. Limited
  • Merck KGaA
North America Cyclodextrin Market Report Segmentation

By Type (Volume, Tonnes, USD Million, 2020-2031)
  • Beta-Cyclodextrin
  • Alpha-Cyclodextrin
  • Gamma-Cyclodextrin
By End-use (Volume, Tonnes, USD Million, 2020-2031)
  • Pharmaceutical
  • Food
  • Cosmetics & Personal Care
  • Chemical
  • Textile
  • Others
By Country (Volume, Tonnes, USD Million, 2020-2031)
  • US
  • Canada
  • Mexico
  • Rest of North America


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cyclodextrin Market, by Type
1.4.2 North America Cyclodextrin Market, by End-use
1.4.3 North America Cyclodextrin Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. North America Cyclodextrin Market by Type
4.1 North America Beta-Cyclodextrin Market by Country
4.2 North America Alpha-Cyclodextrin Market by Country
4.3 North America Gamma-Cyclodextrin Market by Country
Chapter 5. North America Cyclodextrin Market by End-use
5.1 North America Pharmaceutical Market by Country
5.2 North America Food Market by Country
5.3 North America Cosmetics & Personal Care Market by Country
5.4 North America Chemical Market by Country
5.5 North America Textile Market by Country
5.6 North America Others Market by Country
Chapter 6. North America Cyclodextrin Market by Country
6.1 US Cyclodextrin Market
6.1.1 US Cyclodextrin Market by Type
6.1.2 US Cyclodextrin Market by End-use
6.2 Canada Cyclodextrin Market
6.2.1 Canada Cyclodextrin Market by Type
6.2.2 Canada Cyclodextrin Market by End-use
6.3 Mexico Cyclodextrin Market
6.3.1 Mexico Cyclodextrin Market by Type
6.3.2 Mexico Cyclodextrin Market by End-use
6.4 Rest of North America Cyclodextrin Market
6.4.1 Rest of North America Cyclodextrin Market by Type
6.4.2 Rest of North America Cyclodextrin Market by End-use
Chapter 7. Company Profiles
7.1 Midas Pharma GmbH
7.1.1 Company Overview
7.2 Wacker Chemie AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.6 SWOT Analysis
7.3 Roquette Freres SA
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Partnerships, Collaborations, and Agreements:
7.3.3 SWOT Analysis
7.4 Cambrex Corporation
7.4.1 Company Overview
7.4.2 SWOT Analysis
7.5 Wellona Pharma
7.5.1 Company Overview
7.6 Cayman Chemical Company, Inc.
7.6.1 Company Overview
7.6.2 SWOT Analysis
7.7 Cyclolab Kft.
7.7.1 Company Overview
7.8 Ligand Pharmaceuticals Incorporated
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Research & Development Expenses
7.9 Tocopharm Co. Limited
7.9.1 Company Overview
7.10. Merck KGaA
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings